Two laboratory reports can list the same substance and still describe measurements that are not directly comparable. The instrument name is only one part of the explanation. Sample preparation, separation conditions, calibration, the surrounding material and the exact quantity being reported all help define a result.
A method is more than an instrument
High-performance liquid chromatography, or HPLC, and gas chromatography, or GC, are families of separation techniques. Neither abbreviation identifies a complete procedure. Laboratories must also specify how the sample is prepared, how compounds are distinguished, how the detector responds and how signals become reported concentrations.
Consequently, the statement “both laboratories used chromatography” does not establish that they measured the same thing in the same way. Eurachem's method-validation guide treats fitness for purpose as a central question. The relevant evidence concerns the complete method in its intended application.
The sample matrix can change the challenge
The matrix is the material surrounding the substance being measured. A clear aqueous solution, an oil and a powdered botanical material present different analytical conditions. The same nominal concentration does not mean that extraction and measurement will be equally straightforward in each.
Matrix components can interfere with separation, extraction or detector response. In the specific context of biological samples, FDA's bioanalytical-validation guidance discusses effects such as signal suppression, enhancement and extraction efficiency. Those examples illustrate why matrix performance must be investigated; they are not universal validation criteria for every consumer-material test.
Separation is evidence, not a guarantee
Chromatography aims to distinguish components, but signals from different substances can overlap. A result therefore depends partly on whether the procedure separates the target from relevant interferences. More sophisticated equipment does not remove the need to demonstrate that distinction.
A 2026 NIST study of liquid-chromatography columns found that an existing separation method was unsuitable when particular interferences were present. The narrow lesson is important: performance established for one set of samples should not be extended automatically to samples with different interfering components.
Different procedures may still agree
Methods are not necessarily incompatible simply because they use different techniques. A NIST study examining GC–MS measurement biases reported comparability with liquid-chromatography results under the study's evaluated conditions. Such agreement is something to demonstrate with evidence, rather than assume from technique labels alone.
This also means a disagreement does not immediately identify which result is wrong. Before drawing that conclusion, check whether the laboratories examined comparable samples, reported the same chemical form or calculated quantity, and used the same units and moisture basis.
Questions for comparing reports
- What exact substance or defined total was reported?
- Were the sample materials and preparation steps comparable?
- Was the procedure evaluated for that matrix?
- How were relevant interferences addressed?
- Do units, reporting bases and uncertainty statements align?
For example, comparing a concentration on a dry-mass basis with one on an as-received basis can create an apparent discrepancy without any instrument failure. Likewise, comparing two different defined totals may answer two different questions. Resolve these documentary differences before interpreting the numbers as conflicting measurements.
The useful question is not which technique always wins. It is whether each complete procedure provides suitable evidence for the particular measurement and whether the results have a sound basis for comparison.
Sources
- Eurachem: Method Validation
- FDA: Bioanalytical Method Validation
- NIST: Evaluating different C18 columns
- NIST: GC–MS method biases and comparability